Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20186) 20186
Publication (1210) 1210
Newsletter (452) 452
Book Review (260) 260
Book Chapter (126) 126
Magazine Article (57) 57
Book / eBook (39) 39
Conference Proceeding (29) 29
Dissertation (9) 9
Newspaper Article (5) 5
Data Set (3) 3
Reference (3) 3
Web Resource (3) 3
Government Document (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15000) 15000
male (11633) 11633
index medicus (6980) 6980
hyperplasia (6343) 6343
female (6095) 6095
middle aged (5529) 5529
aged (4611) 4611
animals (4426) 4426
prostatic hyperplasia - drug therapy (3630) 3630
adult (3568) 3568
urology & nephrology (3102) 3102
benign prostatic hyperplasia (2985) 2985
treatment outcome (2250) 2250
prostate (1868) 1868
rats (1563) 1563
prostatic hyperplasia - complications (1508) 1508
cancer (1461) 1461
aged, 80 and over (1450) 1450
surgery (1377) 1377
care and treatment (1278) 1278
men (1275) 1275
hypertrophy (1266) 1266
endocrinology & metabolism (1260) 1260
research (1240) 1240
time factors (1235) 1235
analysis (1234) 1234
adolescent (1233) 1233
oncology (1227) 1227
mice (1212) 1212
pharmacology & pharmacy (1185) 1185
therapy (1171) 1171
expression (1169) 1169
adrenergic alpha-antagonists - therapeutic use (1123) 1123
child (1086) 1086
follow-up studies (1060) 1060
risk factors (1054) 1054
medicine & public health (996) 996
inflammation (985) 985
disease models, animal (982) 982
finasteride (952) 952
health aspects (947) 947
restenosis (915) 915
cardiac & cardiovascular systems (907) 907
intimal hyperplasia (902) 902
urology (901) 901
urinary-tract symptoms (900) 900
prospective studies (895) 895
diagnosis (882) 882
adrenal hyperplasia, congenital - drug therapy (872) 872
prostatic hyperplasia - pathology (861) 861
medicine, general & internal (855) 855
prostate cancer (791) 791
drug therapy (786) 786
drug therapy, combination (777) 777
retrospective studies (775) 775
tunica intima - pathology (763) 763
peripheral vascular disease (751) 751
efficacy (747) 747
prostatic hyperplasia - surgery (746) 746
pathology (740) 740
lower urinary tract symptoms (737) 737
apoptosis (725) 725
quality of life (724) 724
prostatic hyperplasia - physiopathology (718) 718
immunohistochemistry (716) 716
double-blind method (713) 713
dose-response relationship, drug (694) 694
prostate - pathology (692) 692
medicine (672) 672
abridged index medicus (657) 657
proliferation (654) 654
obstetrics & gynecology (649) 649
article (643) 643
child, preschool (642) 642
disease (638) 638
diagnosis, differential (629) 629
stents (629) 629
cells, cultured (624) 624
rats, sprague-dawley (622) 622
hyperplasia - pathology (611) 611
biopsy (610) 610
management (608) 608
neointimal hyperplasia (602) 602
prostatic hyperplasia - therapy (602) 602
tamsulosin (585) 585
pregnancy (565) 565
double-blind (563) 563
medicine, research & experimental (563) 563
prostate - drug effects (563) 563
cell proliferation - drug effects (559) 559
finasteride - therapeutic use (551) 551
research article (551) 551
prostatic hyperplasia (544) 544
cell biology (542) 542
growth (534) 534
gene expression (523) 523
risk (523) 523
testosterone (522) 522
prevalence (519) 519
carcinoma (518) 518
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (28) 28
Online Resources - Online (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18760) 18760
German (481) 481
Russian (305) 305
French (289) 289
Japanese (276) 276
Italian (189) 189
Spanish (163) 163
Chinese (137) 137
Polish (49) 49
Hungarian (30) 30
Portuguese (22) 22
Czech (21) 21
Danish (21) 21
Swedish (14) 14
Bulgarian (13) 13
Dutch (11) 11
Korean (11) 11
Hebrew (9) 9
Norwegian (9) 9
Romanian (9) 9
Turkish (8) 8
Croatian (6) 6
Slovak (6) 6
Finnish (5) 5
Ukrainian (4) 4
Persian (3) 3
Serbian (3) 3
Afrikaans (2) 2
Bosnian (2) 2
Greek (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Drug therapy - Herbal remedies
by De Smet, PAGM
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 12/2002, Volume 347, Issue 25, pp. 2046 - 2056
BENIGN PROSTATIC HYPERPLASIA | RANDOMIZED CONTROLLED TRIAL | MEDICINE, GENERAL & INTERNAL | HYPERICUM-PERFORATUM | CLINICAL-TRIALS | PLACEBO-CONTROLLED TRIALS | DOUBLE-BLIND | GINKGO-BILOBA EXTRACT | INTERMITTENT CLAUDICATION | ST-JOHNS-WORT | MAJOR DEPRESSION
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Drug therapy - Management of overactive bladder
by Ouslander, JG
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 02/2004, Volume 350, Issue 8, pp. 786 - 799
BENIGN PROSTATIC HYPERPLASIA | MEDICINE, GENERAL & INTERNAL | STANDARDIZATION SUB-COMMITTEE | GERIATRIC VOIDING DYSFUNCTION | NURSING-HOME RESIDENTS | RANDOMIZED CONTROLLED-TRIAL | QUALITY-OF-LIFE | INTERNATIONAL CONTINENCE SOCIETY | CONTROLLED-RELEASE OXYBUTYNIN | LONG-TERM EFFICACY | LOWER URINARY-TRACT
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Systematic Review of Combination Drug Therapy for Non-neurogenic Male Lower Urinary Tract Symptoms
by Füllhase, Claudius and Chapple, Christopher and Cornu, Jean-Nicolas and De Nunzio, Cosimo and Gratzke, Christian and Kaplan, Steven A and Marberger, Michael and Montorsi, Francesco and Novara, Giacomo and Oelke, Matthias and Porst, Hartmut and Roehrborn, Claus and Stief, Christian and McVary, Kevin T
European Urology, ISSN 0302-2838, 2013, Volume 64, Issue 2, pp. 228 - 243
Abstract Background Several drugs are approved for the treatment of lower urinary tract symptoms (LUTS) in men, but these are mostly used by clinicians as... 
Urology | Muscarinic antagonists | Prostatic hyperplasia | 5α-reductase inhibitors | Lower urinary tract symptoms | Adrenergic α1-receptor antagonists | TOLTERODINE EXTENDED-RELEASE | OVERACTIVE BLADDER SYMPTOMS | PHOSPHODIESTERASE-5 INHIBITOR | RANDOMIZED CONTROLLED-TRIAL | BENIGN PROSTATIC HYPERPLASIA | ALPHA-BLOCKER | 5 alpha-reductase inhibitors | UROLOGY & NEPHROLOGY | QUALITY-OF-LIFE | COMBINED ORAL-THERAPY | Adrenergic alpha-receptor antagonists | TREATMENT SATISFACTION | ERECTILE DYSFUNCTION | Phosphodiesterase 5 Inhibitors - adverse effects | Humans | Muscarinic Antagonists - adverse effects | Lower Urinary Tract Symptoms - physiopathology | Male | Treatment Outcome | 5-alpha Reductase Inhibitors - therapeutic use | Muscarinic Antagonists - therapeutic use | Evidence-Based Medicine | Prostatic Hyperplasia - diagnosis | Lower Urinary Tract Symptoms - drug therapy | Time Factors | Adrenergic alpha-1 Receptor Antagonists - therapeutic use | 5-alpha Reductase Inhibitors - adverse effects | Lower Urinary Tract Symptoms - diagnosis | Adrenergic alpha-1 Receptor Antagonists - adverse effects | Phosphodiesterase 5 Inhibitors - therapeutic use | Prostatic Hyperplasia - physiopathology | Drug Therapy, Combination | Prostatic Hyperplasia - drug therapy | Drugs | Medical colleges | Hospitals | Drug therapy, Combination | Drug approval
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Systematic Review of Combination Drug Therapy for Non-neurogenic Lower Urinary Tract Symptoms
by Serati, Maurizio and Andersson, Karl-Erik and Dmochowski, Roger and Agrò, Enrico Finazzi and Heesakkers, John and Iacovelli, Valerio and Novara, Giacomo and Khullar, Vik and Chapple, Christopher and Division of Clinical Chemistry and Pharmacology and Avdelningen för klinisk kemi och farmakologi and Lund University and Lunds universitet
European Urology, ISSN 0302-2838, 01/2019, Volume 75, Issue 1, pp. 129 - 168
Several drugs are approved and available for the treatment of lower urinary tract symptoms (LUTS) in men and women. However, the vast majority of available... 
Antimuscarinics | Benign prostatic hyperplasia | Overactive bladder | α1-Adrenoceptor antagonist | Adrenergic β3 receptor agonists | Adrenergic beta 3 receptor agonists | ENLARGEMENT SECONDARY | alpha 1-Adrenoceptor antagonist | OVERACTIVE BLADDER SYMPTOMS | CONTROLLED ABSORPTION SYSTEM | OUTLET OBSTRUCTION | ADD-ON THERAPY | ALPHA-BLOCKER | CONTINENCE SOCIETY | UROLOGY & NEPHROLOGY | QUALITY-OF-LIFE | POSTMENOPAUSAL WOMEN | Lower Urinary Tract Symptoms - drug therapy | Drug Therapy, Combination | Lower Urinary Tract Symptoms - etiology | Humans | Lower Urinary Tract Symptoms - diagnosis | Urological Agents - therapeutic use | Analysis | Drug therapy, Combination | Urologi och njurmedicin | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Urology and Nephrology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus. The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients)
by Lee, Seung-Whan and Park, Seong-Wook and Kim, Young-Hak and Yun, Sung-Cheol and Park, Duk-Woo and Lee, Cheol Whan and Hong, Myeong-Ki and Kim, Hyun-Sook and Ko, Jae-Ki and Park, Jae-Hyeong and Lee, Jae-Hwan and Choi, Si Wan and Seong, In-Whan and Cho, Yoon Haeng and Lee, Nae-Hee and Kim, June Hong and Chun, Kook-Jin and Park, Seung-Jung
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2008, Volume 51, Issue 12, pp. 1181 - 1187
Objectives: We sought to evaluate the impact of cilostazol on neointimal hyperplasia after drug-eluting stent (DES) implantation in patients with diabetes... 
CARDIAC & CARDIOVASCULAR SYSTEMS | PREDICTORS | Coronary Vessels - drug effects | Drug-Eluting Stents | Humans | Hyperplasia | Middle Aged | Male | Treatment Outcome | Coronary Restenosis - drug therapy | Diabetes Mellitus | Ticlopidine - analogs & derivatives | Aspirin - administration & dosage | Tunica Intima - drug effects | Coronary Angiography | Coronary Artery Disease - diagnostic imaging | Coronary Restenosis - complications | Coronary Artery Disease - therapy | Tetrazoles - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - administration & dosage | Diabetic Angiopathies - complications | Female | Aged | Drug Therapy, Combination | Heart attacks | Angina pectoris | Angioplasty | Stents | Clinical outcomes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Combination drug therapy in patients with BPH
by Kuzmenko, A.V and Kuzmenko, V.V and Gyaurgiev, T.A
Urologiia (Moscow, Russia : 1999), ISSN 1728-2985, 03/2018, Issue 1, pp. 101 - 105
5-reductase inhibitors and -blockers | Duodart | benign prostatic hyperplasia | prostate adenoma
Journal Article
Details down arrow
7. Full Text Three-Year Treatment Outcomes of Water Vapor Thermal Therapy Compared to Doxazosin, Finasteride and Combination Drug Therapy in Men with Benign Prostatic Hyperplasia: Cohort Data from the MTOPS Trial
by Gupta, Nikhil and Rogers, Tyson and Holland, Bradley and Helo, Sevann and Dynda, Danuta and McVary, Kevin T
The Journal of Urology, ISSN 0022-5347, 08/2018, Volume 200, Issue 2, pp. 405 - 413
We evaluated the long-term outcomes of treatment of lower urinary tract symptoms due to benign prostatic hyperplasia to compare a 1-time water vapor thermal... 
hyperthermia | doxazosin | lower urinary tract symptoms | finasteride | benign prostatic hyperplasia | induced | MULTICENTER | EFFICACY | SECONDARY | URINARY-TRACT SYMPTOMS | REZUM((R)) SYSTEM | UROLOGY & NEPHROLOGY | PATIENT | 5-ALPHA REDUCTASE INHIBITORS | hyperthermia, induced | ERECTILE DYSFUNCTION | Doxazosin | Finasteride | Patient outcomes | Clinical trials | Drug therapy, Combination | Comparative analysis | Drug therapy | Prostate | Hypertrophy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Efficacy of adding behavioural treatment or antimuscarinic drug therapy to -blocker therapy in men with nocturia
by Johnson, TM and Markland, AD and Goode, PS and Vaughan, CP and Colli, JL and Ouslander, JG and Redden, DT and McGwin, G and Burgio, KL
BJU INTERNATIONAL, ISSN 1464-4096, 07/2013, Volume 112, Issue 1, pp. 100 - 108
What's known on the subject? and What does the study add? Nocturia is a common and bothersome lower urinary tract symptom, particularly in men. Many single... 
TOLTERODINE | RANDOMIZED CONTROLLED-TRIAL | BENIGN PROSTATIC HYPERPLASIA | WOMEN | exercise therapy | OVERACTIVE BLADDER | DWELLING OLDER-ADULTS | DOUBLE-BLIND | UROLOGY & NEPHROLOGY | nocturia | muscarinic antagonists | PLACEBO-CONTROLLED TRIAL | lower urinary tract symptoms | DESMOPRESSIN | ASSOCIATION | adrenergic -blockers | Behavioral health care | Oxybutynin | Behavior modification | Exercise therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Drug therapy of urethral diseases
by Game, X and Cornu, J-N and Robert, G and Descazeaud, A and Droupy, S and Benard-Laribiere, A and Bastide, C and Guy, L and Bruyére, F and Karsenty, G
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, ISSN 1166-7087, 11/2013, Volume 23, Issue 15, p. 1287
To describe drugs targeting urethra and prostate to treat dysfunctions such LUTS related to BPH, primary bladder neck obstruction (PBNO), detrusor sphincter... 
Humans | Serotonin Uptake Inhibitors - therapeutic use | Adrenergic alpha-Antagonists - therapeutic use | Male | 5-alpha Reductase Inhibitors - therapeutic use | Fatty Alcohols - therapeutic use | Neuromuscular Agents - therapeutic use | Botulinum Toxins, Type A - therapeutic use | Androgen Antagonists - therapeutic use | Urethral Diseases - drug therapy | Phosphodiesterase 5 Inhibitors - therapeutic use | Phytotherapy | Plant Extracts - therapeutic use | Prostatic Hyperplasia - drug therapy | Prunus africana
Journal Article
Details down arrow
10. Full Text Parathyroid Nodular Hyperplasia and Responsiveness to Drug Therapy in Renal Secondary Hyperparathyroidism: An Open Question
by Vulpio, Carlo and Bossola, Maurizio
Therapeutic Apheresis and Dialysis, ISSN 1744-9979, 02/2018, Volume 22, Issue 1, pp. 11 - 21
The goal of the pharmacological therapy in secondary hyperparathyroidism (SHPT) is to reduce serum levels of parathyroid hormone and phosphorus, to correct... 
Parathyroid hyperplasia | Vitamin D | Cinacalcet | Hemodialysis | Secondary hyperparathyroidism | Ultrasonography | CINACALCET HYDROCHLORIDE | CHRONIC-HEMODIALYSIS PATIENTS | SURGICAL-TREATMENT | CALCIUM-SENSING RECEPTOR | INTRAVENOUS CALCITRIOL THERAPY | UROLOGY & NEPHROLOGY | MINERAL METABOLISM | GLAND SIZE | CHRONIC KIDNEY-DISEASE | HEMATOLOGY | CHRONIC DIALYSIS PATIENTS | LEFT-VENTRICULAR FUNCTION | Hyperparathyroidism, Secondary - drug therapy | Humans | Hyperplasia | Calcium Channel Agonists - therapeutic use | Treatment Outcome | Cinacalcet Hydrochloride - therapeutic use | Calcitriol - therapeutic use | Parathyroid Glands - pathology | Calcimimetic Agents - therapeutic use | Parathyroid hormone | Calcifediol | Alfacalcidol | Drug therapy | Hyperparathyroidism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Safety and Effectiveness of Bipolar Transurethral Resection of the Prostate in Patients Under Ongoing Oral Anticoagulation with Coumarins or Antiplatelet Drug Therapy Compared to Patients Without Anticoagulation/Antiplatelet Therapy
by Rühle, Annika and Blarer, Jennifer and Oehme, Florian and Marini, Lorenzo and Mattei, Agostino and Stucki, Patrick and Danuser, Hansjörg
Journal of Endourology, ISSN 0892-7790, 06/2019, Volume 33, Issue 6, pp. 455 - 462
Objective: To determine whether transurethral resection of the prostate (TURP) is safe and effective in patients under ongoing therapeutic oral anticoagulation... 
Transurethral and Lower Tract Procedures | INTERVENTIONS | MORBIDITY | ongoing antiplatelet drug therapy | transurethral resection of the prostate | UROLOGY & NEPHROLOGY | RISK | ongoing oral anticoagulation therapy | OUTCOMES | HOLMIUM LASER ENUCLEATION | benign prostate hyperplasia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Drug therapy - Angiotensin receptors and their antagonists
by Goodfriend, TL and Elliott, ME and Catt, KJ
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 06/1996, Volume 334, Issue 25, pp. 1649 - 1654
  Angiotensin II also increases the entry of calcium into the cell through channels in the cell membrane.33 Calcium and diacylglycerol activate enzymes,... 
CALCIUM SIGNAL | HYPERTROPHY | RESPONSES | MEDICINE, GENERAL & INTERNAL | INHIBITION | HEALTHY-SUBJECTS | II RECEPTOR | NORMAL VOLUNTEERS | GLOMERULOSA CELLS | HYPERPLASIA | SMOOTH-MUSCLE CELLS | Hypertension | Blood pressure | Pathogenesis | Rodents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Bladder Storage and Voiding Dysfunctions Side Effects of drug Therapy
by Wolfesberger, J and Falkensammer, CE and Madersbacher, S
UROLOGE, ISSN 0340-2592, 04/2017, Volume 56, Issue 4, pp. 456 - 464
Bladder storage and voiding dysfunctions primarily affect patients aged 60 and upwards. Demographic changes and an age-related rise in prevalence underline the... 
BENIGN PROSTATIC HYPERPLASIA | BETA-ADRENOCEPTOR AGONIST | EFFICACY | SAFETY | URINARY-TRACT SYMPTOMS | MEN | DOUBLE-BLIND | UROLOGY & NEPHROLOGY | ALPHA-BLOCKERS | 5-ALPHA-REDUCTASE INHIBITORS | SEXUAL FUNCTION | Urinary Bladder Diseases - complications | Humans | Muscarinic Antagonists - adverse effects | Urination Disorders - drug therapy | Adrenergic alpha-Antagonists - therapeutic use | Treatment Outcome | Muscarinic Antagonists - therapeutic use | Evidence-Based Medicine | Urological Agents - adverse effects | Adrenergic alpha-Antagonists - adverse effects | Drug-Related Side Effects and Adverse Reactions | Urinary Bladder Diseases - drug therapy | Urination Disorders - complications | Urological Agents - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text What is the role of combination drug therapy in the treatment of overactive bladder? ICI‐RS 2014
by Visco, Anthony G and Fraser, Matthew O and Newgreen, Donald and Oelke, Matthias and Cardozo, Linda
Neurourology and Urodynamics, ISSN 0733-2467, 02/2016, Volume 35, Issue 2, pp. 288 - 292
Aims and Methods The role of combination therapy using oral antimuscarinic medications for the treatment of overactive bladder was proposed at the 2014... 
anticholinergic medication | urge urinary incontinence | combination therapy | lower urinary tract dysfunction | antimuscarinic medication | overactive bladder | EFFICACY | SAFETY | MIRABEGRON | TOLTERODINE | TAMSULOSIN | SYMPTOMS | TADALAFIL | RECEPTOR ANTAGONIST | BENIGN PROSTATIC HYPERPLASIA | DOUBLE-BLIND | UROLOGY & NEPHROLOGY | Drug Costs | Congresses as Topic | Muscarinic Antagonists - economics | Urinary Bladder, Overactive - diagnosis | Administration, Oral | Humans | Muscarinic Antagonists - adverse effects | Urodynamics - drug effects | Treatment Outcome | Urinary Bladder, Overactive - economics | Recovery of Function | Muscarinic Antagonists - administration & dosage | Urinary Bladder, Overactive - drug therapy | Animals | Drug Interactions | Urinary Bladder, Overactive - physiopathology | Cost-Benefit Analysis | Urinary Bladder - physiopathology | Urinary Bladder - drug effects | Drug Therapy, Combination | Drugs | Urinary incontinence | Drug therapy, Combination | Drug therapy | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Comparative effectiveness of oral drug therapies for lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and network meta-analysis
by Wang, Xinghuan and Wang, Xinghuan and Wang, Xiao and Wang, Xiao and Li, Sheng and Li, Sheng and Meng, Zhe and Meng, Zhe and Liu, Tao and Liu, Tao and Zhang, Xinhua and Zhang, Xinhua
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 9, p. e107593
Introduction: Lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) are common in elder men and a number of drugs alone or combined are... 
CONTROLLED CLINICAL-TRIAL | GASTROINTESTINAL THERAPEUTIC SYSTEM | SPONTANEOUSLY HYPERTENSIVE-RATS | DOUBLE-BLIND TRIAL | MULTIDISCIPLINARY SCIENCES | POPULATION-BASED SURVEY | BLADDER OUTLET OBSTRUCTION | SELECTIVE ALPHA(1A)-ADRENOCEPTOR ANTAGONIST | RANDOMIZED CONTROLLED-TRIAL | PLACEBO-CONTROLLED TRIAL | TAMSULOSIN 0.4 MG | Prostatic Hyperplasia - pathology | Lower Urinary Tract Symptoms - drug therapy | Lower Urinary Tract Symptoms - etiology | Lower Urinary Tract Symptoms - pathology | Humans | Male | 5-alpha Reductase Inhibitors - therapeutic use | Phosphodiesterase 5 Inhibitors - therapeutic use | Muscarinic Antagonists - therapeutic use | Prostatic Hyperplasia - drug therapy | Prostatic Hyperplasia - complications | Randomized Controlled Trials as Topic | Drugs | Online searching | Development and progression | Internet/Web search services | Database searching | Comparative analysis | Drug therapy | Prostate | Hypertrophy | Therapy | Acetylcholine receptors (muscarinic) | Hyperplasia | Medical services | Clinical trials | Bladder | Smooth muscle | Systematic review | Urinary tract | Urology | Information systems | Urogenital system | Phosphodiesterase | Hypertension | Medical treatment | Benign | Flow rates | Pharmacology | Meta-analysis | Studies | Inhibitors | Storage | Flow velocity | Reductase
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
by Rubbia-Brandt, Laura and Audard, V and Sartoretti, P and Roth, A.D and Brezault, C and Le Charpentier, M and Dousset, B and Morel, P and Soubrane, O and Chaussade, S and Mentha, G and Terris, B
Annals of Oncology, ISSN 0923-7534, 03/2004, Volume 15, Issue 3, pp. 460 - 466
Background: In advanced metastatic colorectal adenocarcinoma, the addition of a neo-adjuvant systemic treatment to surgery might translate into a survival... 
5-fluorouracil | Veno-occlusive disease | Sinusoidal obstruction syndrome | Neo-adjuvant chemotherapy | Drug liver injury | 1ST-LINE TREATMENT | MULTICENTER RANDOMIZED-TRIAL | LEUCOVORIN | VENOOCCLUSIVE DISEASE | sinusoidal obstruction syndrome | STELLATE CELLS | FLUOROURACIL | LIVER METASTASES | NODULAR REGENERATIVE HYPERPLASIA | ONCOLOGY | GLUTATHIONE | drug liver injury | neo-adjuvant chemotherapy | MARROW-TRANSPLANTATION | veno-occlusive disease | Prognosis | Hepatic Veno-Occlusive Disease - surgery | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Liver Cirrhosis - chemically induced | Hepatectomy | Oxaliplatin | Liver - drug effects | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Hepatic Veno-Occlusive Disease - pathology | Liver - surgery | Liver Neoplasms - secondary | Liver - ultrastructure | Cells, Cultured | Liver Neoplasms - surgery | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Hepatic Veno-Occlusive Disease - chemically induced | Liver Cirrhosis - pathology | Liver Cirrhosis - surgery | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights